| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
27,742 |
23,108 |
$2.57M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,465 |
11,382 |
$1.15M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,013 |
10,639 |
$910K |
| 36415 |
Collection of venous blood by venipuncture |
24,611 |
17,294 |
$677K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,264 |
3,721 |
$605K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,986 |
5,495 |
$454K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,914 |
7,983 |
$349K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
990 |
875 |
$334K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
6,159 |
5,105 |
$316K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,460 |
1,248 |
$291K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
754 |
705 |
$281K |
| 80053 |
Comprehensive metabolic panel |
19,243 |
15,456 |
$261K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,993 |
4,137 |
$209K |
| 59025 |
Fetal non-stress test |
2,123 |
1,742 |
$193K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,929 |
2,418 |
$191K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
9,823 |
7,134 |
$187K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,964 |
1,258 |
$178K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,326 |
972 |
$178K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,563 |
3,145 |
$176K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,625 |
2,423 |
$132K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,434 |
1,317 |
$118K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,609 |
1,436 |
$107K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,200 |
9,850 |
$92K |
| 71046 |
Radiologic examination, chest; 2 views |
4,581 |
4,094 |
$90K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,553 |
1,890 |
$85K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,690 |
1,505 |
$82K |
| G0378 |
Hospital observation service, per hour |
9,542 |
4,037 |
$82K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,688 |
3,793 |
$73K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
624 |
529 |
$73K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
81 |
74 |
$73K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,803 |
2,620 |
$66K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
923 |
829 |
$65K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,396 |
1,301 |
$64K |
| 71250 |
|
1,674 |
1,445 |
$60K |
| 76536 |
|
819 |
774 |
$59K |
| 76642 |
|
1,148 |
1,072 |
$59K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,201 |
1,069 |
$58K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
811 |
697 |
$53K |
| 82962 |
|
8,026 |
4,454 |
$52K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,647 |
2,512 |
$52K |
| 76830 |
Ultrasound, transvaginal |
1,869 |
1,708 |
$50K |
| 86901 |
|
2,354 |
1,936 |
$49K |
| 93017 |
|
1,611 |
1,393 |
$48K |
| 77066 |
Tomosynthesis, mammo |
889 |
831 |
$46K |
| A9270 |
Non-covered item or service |
12,079 |
5,030 |
$44K |
| 72100 |
|
1,139 |
1,070 |
$42K |
| 93970 |
|
1,047 |
921 |
$39K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,341 |
3,095 |
$38K |
| 95811 |
|
128 |
113 |
$36K |
| 93971 |
|
1,324 |
1,173 |
$35K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
286 |
254 |
$34K |
| 86850 |
|
1,657 |
1,323 |
$33K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
28,403 |
20,371 |
$32K |
| 97162 |
|
929 |
800 |
$32K |
| 76770 |
|
424 |
390 |
$32K |
| 73562 |
|
1,729 |
1,368 |
$30K |
| 72040 |
|
846 |
796 |
$30K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
10,279 |
7,622 |
$29K |
| 73030 |
|
1,293 |
1,098 |
$28K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
359 |
317 |
$24K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
272 |
248 |
$24K |
| 71045 |
Radiologic examination, chest; single view |
12,186 |
10,120 |
$24K |
| 81001 |
|
8,364 |
7,163 |
$23K |
| 87210 |
|
1,273 |
1,156 |
$23K |
| 73630 |
|
1,512 |
1,235 |
$22K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
561 |
496 |
$22K |
| 81002 |
|
920 |
767 |
$21K |
| 77080 |
|
575 |
498 |
$20K |
| 73610 |
|
856 |
739 |
$20K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14,976 |
11,827 |
$19K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,549 |
2,267 |
$19K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,687 |
2,899 |
$18K |
| 84112 |
|
120 |
109 |
$18K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,106 |
935 |
$17K |
| 73130 |
|
733 |
598 |
$15K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,272 |
5,517 |
$14K |
| 76801 |
|
1,129 |
968 |
$14K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,225 |
1,157 |
$14K |
| 87400 |
|
1,520 |
786 |
$13K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,405 |
2,039 |
$13K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
337 |
130 |
$13K |
| 81003 |
|
3,858 |
3,396 |
$13K |
| 87081 |
|
463 |
432 |
$12K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
484 |
438 |
$12K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,124 |
990 |
$12K |
| 86900 |
|
2,079 |
1,699 |
$11K |
| 84484 |
|
11,758 |
8,310 |
$11K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
7,459 |
5,864 |
$11K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
161 |
110 |
$11K |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,836 |
1,779 |
$11K |
| 81025 |
|
4,324 |
3,862 |
$10K |
| 73502 |
|
570 |
503 |
$10K |
| 72110 |
|
697 |
624 |
$10K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,359 |
1,930 |
$10K |
| 82731 |
|
57 |
53 |
$9K |
| 97161 |
|
169 |
152 |
$9K |
| 99152 |
|
619 |
506 |
$9K |
| 87631 |
|
102 |
94 |
$9K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,873 |
1,555 |
$8K |
| 84703 |
|
4,071 |
3,575 |
$8K |
| J1815 |
Injection, insulin, per 5 units |
2,671 |
1,152 |
$8K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
142 |
140 |
$8K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
154 |
130 |
$8K |
| 84702 |
|
1,701 |
1,359 |
$7K |
| 77065 |
Tomosynthesis, mammo |
151 |
140 |
$7K |
| 80061 |
Lipid panel |
2,149 |
1,823 |
$7K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
16 |
13 |
$7K |
| G0379 |
Direct admission of patient for hospital observation care |
177 |
150 |
$7K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,829 |
1,894 |
$7K |
| 97163 |
|
130 |
115 |
$7K |
| 96376 |
|
2,764 |
1,641 |
$7K |
| 85610 |
|
4,675 |
3,596 |
$7K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,350 |
2,616 |
$6K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,505 |
1,084 |
$6K |
| 87641 |
|
378 |
281 |
$6K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,333 |
803 |
$6K |
| 85730 |
|
3,275 |
2,577 |
$6K |
| 73110 |
|
237 |
211 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,246 |
1,906 |
$5K |
| C1769 |
Guide wire |
290 |
227 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
90 |
75 |
$5K |
| 74240 |
|
57 |
56 |
$5K |
| 29581 |
|
47 |
12 |
$5K |
| 74018 |
|
278 |
253 |
$5K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
23 |
14 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
105 |
93 |
$5K |
| 83735 |
|
3,539 |
2,435 |
$5K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,329 |
1,055 |
$5K |
| 99153 |
Mod sedat endo service >5yrs |
307 |
246 |
$4K |
| 83880 |
|
3,157 |
2,586 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,208 |
2,368 |
$4K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,161 |
971 |
$4K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
229 |
177 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,668 |
4,015 |
$3K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
28 |
25 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,467 |
1,855 |
$3K |
| 72072 |
|
111 |
101 |
$3K |
| 71271 |
|
39 |
38 |
$3K |
| J2704 |
Injection, propofol, 10 mg |
1,863 |
1,506 |
$3K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
266 |
214 |
$2K |
| 10060 |
|
12 |
12 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
43 |
38 |
$2K |
| 94726 |
|
40 |
39 |
$2K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
561 |
410 |
$2K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
741 |
478 |
$2K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
266 |
213 |
$2K |
| 97116 |
|
127 |
94 |
$2K |
| 70486 |
|
72 |
65 |
$2K |
| 83690 |
|
4,971 |
4,215 |
$1K |
| 80076 |
|
134 |
116 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,587 |
1,357 |
$1K |
| 87077 |
|
417 |
333 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,392 |
1,094 |
$1K |
| J1245 |
Injection, dipyridamole, per 10 mg |
395 |
320 |
$1K |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
286 |
208 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,117 |
845 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
600 |
546 |
$962.54 |
| 94060 |
|
43 |
40 |
$951.51 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13 |
12 |
$886.32 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
605 |
551 |
$884.52 |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
446 |
426 |
$836.29 |
| 88341 |
|
16 |
12 |
$826.77 |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
16 |
13 |
$788.09 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
620 |
512 |
$747.20 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
813 |
626 |
$712.83 |
| 88342 |
|
37 |
29 |
$691.14 |
| 93880 |
|
45 |
37 |
$680.97 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
179 |
135 |
$643.48 |
| 85379 |
|
573 |
507 |
$633.97 |
| 83605 |
|
3,104 |
2,597 |
$579.25 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
970 |
930 |
$565.33 |
| 73080 |
|
15 |
13 |
$501.31 |
| 82565 |
|
232 |
187 |
$480.99 |
| J1750 |
Injection, iron dextran, 50 mg |
16 |
14 |
$393.71 |
| 84145 |
|
125 |
111 |
$387.77 |
| 87186 |
|
755 |
623 |
$387.16 |
| 80329 |
|
688 |
635 |
$343.18 |
| 87205 |
|
127 |
105 |
$300.99 |
| 87070 |
|
33 |
30 |
$285.62 |
| 72131 |
|
26 |
24 |
$283.52 |
| 82570 |
|
72 |
64 |
$274.93 |
| 87430 |
|
442 |
406 |
$241.94 |
| 86140 |
|
410 |
365 |
$222.32 |
| 84132 |
|
127 |
86 |
$209.31 |
| 80320 |
|
494 |
445 |
$197.49 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
77 |
70 |
$185.27 |
| 87040 |
|
822 |
649 |
$162.88 |
| 97166 |
|
76 |
64 |
$137.57 |
| 73590 |
|
26 |
25 |
$136.99 |
| 77062 |
|
90 |
87 |
$125.48 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
191 |
155 |
$124.68 |
| 86923 |
|
34 |
25 |
$106.63 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
246 |
221 |
$97.42 |
| 87634 |
|
156 |
153 |
$86.93 |
| 90715 |
|
29 |
26 |
$84.08 |
| 87807 |
|
12 |
12 |
$81.95 |
| 74021 |
|
67 |
65 |
$74.10 |
| 82803 |
|
19 |
13 |
$40.96 |
| 84550 |
|
62 |
53 |
$38.41 |
| 93325 |
|
23 |
13 |
$29.02 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
33 |
27 |
$26.50 |
| 82077 |
|
371 |
342 |
$24.96 |
| 94729 |
|
42 |
41 |
$21.11 |
| 82607 |
|
45 |
40 |
$19.21 |
| 82247 |
|
15 |
12 |
$18.48 |
| 84439 |
|
268 |
231 |
$16.82 |
| 82550 |
|
179 |
134 |
$9.66 |
| 85027 |
|
148 |
128 |
$7.57 |
| 87147 |
|
42 |
39 |
$5.20 |
| 82248 |
|
33 |
24 |
$4.64 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
192 |
101 |
$4.54 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
179 |
131 |
$4.15 |
| 85014 |
|
45 |
26 |
$3.96 |
| 85652 |
|
174 |
161 |
$3.44 |
| 85018 |
|
47 |
27 |
$1.98 |
| J2785 |
Injection, regadenoson, 0.1 mg |
44 |
35 |
$0.50 |
| 90686 |
|
180 |
137 |
$0.33 |
| G0008 |
Administration of influenza virus vaccine |
172 |
134 |
$0.33 |
| J2060 |
Injection, lorazepam, 2 mg |
239 |
211 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
285 |
251 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
290 |
245 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
31 |
24 |
$0.00 |
| J0280 |
Injection, aminophyllin, up to 250 mg |
14 |
13 |
$0.00 |
| 99406 |
|
25 |
24 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
30 |
24 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
65 |
40 |
$0.00 |
| 83615 |
|
89 |
84 |
$0.00 |
| 97535 |
Self-care/home management training, each 15 minutes |
39 |
33 |
$0.00 |
| 36430 |
|
18 |
12 |
$0.00 |
| 88300 |
|
16 |
15 |
$0.00 |
| 84100 |
|
67 |
50 |
$0.00 |
| 82010 |
|
29 |
26 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
19 |
17 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
96 |
92 |
$0.00 |
| 84156 |
|
44 |
38 |
$0.00 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
17 |
12 |
$0.00 |
| 36600 |
|
19 |
13 |
$0.00 |
| 77061 |
|
12 |
12 |
$0.00 |